Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MDT | Ordinary Shares | Options Exercise | $3.8M | +50.8K | +104.13% | $74.84 | 99.5K | Aug 31, 2021 | Direct | F1 |
transaction | MDT | Ordinary Shares | Sale | -$6.81M | -50.8K | -51.01% | $134.17 | 48.8K | Aug 31, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MDT | Stock Option (Right to Buy) | Options Exercise | $0 | -50.8K | -100% | $0.00* | 0 | Aug 31, 2021 | Ordinary Shares | 50.8K | $74.84 | Direct | F1, F2, F3 |
Id | Content |
---|---|
F1 | This transaction was effected pursuant to a Rule 10b5-1 trading plan. |
F2 | This option becomes exercisable on June 29, 2018, subject to Medtronic's achievement of a pre-specified cash Earnings Per Share Growth Rate for fiscal years 2016 through 2018. |
F3 | This date was previously reported incorrectly as 7/28/2024. |